Theodore L. Harris - Feb 8, 2023 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
Chairman, President & CEO, Director
Signature
/s/ Travis Larsen, Attorney in Fact for Theodore L. Harris
Stock symbol
BCPC
Transactions as of
Feb 8, 2023
Transactions value $
-$1,224,030
Form type
4
Date filed
2/10/2023, 07:35 PM
Previous filing
Jan 4, 2023
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +6.28K +8.76% $0.00 78K Feb 8, 2023 Direct F1, F2
transaction BCPC Common Stock Award $0 +17.3K +22.24% $0.00 95.3K Feb 8, 2023 Direct F3
transaction BCPC Common Stock Tax liability -$1.22M -8.86K -9.3% $138.09* 86.5K Feb 8, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +21.2K $0.00 21.2K Feb 8, 2023 Common Stock 21.2K $138.09 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Includes acquisition of shares under the Balchem Corporation 401(k) plan.
F3 Represents the vesting of performance stock units (includes 256 dividend equivalent shares) for the 2020-2022 performance period.
F4 8,864 of the 17,344 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting.
F5 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Remarks:

Exhibit 24 - Power of Attorney is attached.